How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

446 results for

Cutaneous Candidiasis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

441. Therapeutic efficacy of lanoconazole, a new imidazole antimycotic agent, for experimental cutaneous candidiasis in guinea pigs. (PubMed)

Therapeutic efficacy of lanoconazole, a new imidazole antimycotic agent, for experimental cutaneous candidiasis in guinea pigs. The therapeutic efficacy of 1% cream and 1% solution of lanoconazole, a new imidazole antimycotic agent, in the model of cutaneous candidiasis in prednisolone-treated guinea pigs was evaluated in comparison with that of comparable formulations of bifonazole. Each preparation was topically applied once a day for 3 consecutive days, starting on the fifth day

Full Text available with Trip Pro

1994 Antimicrobial Agents and Chemotherapy

442. In Vitro Antifungal Activity of KP-103, a Novel Triazole Derivative, and Its Therapeutic Efficacy against Experimental Plantar Tinea Pedis and Cutaneous Candidiasis in Guinea Pigs (PubMed)

In Vitro Antifungal Activity of KP-103, a Novel Triazole Derivative, and Its Therapeutic Efficacy against Experimental Plantar Tinea Pedis and Cutaneous Candidiasis in Guinea Pigs The in vitro activity of KP-103, a novel triazole derivative, against pathogenic fungi that cause dermatomycoses and its therapeutic efficacy against plantar tinea pedis and cutaneous candidiasis in guinea pigs were investigated. MICs were determined by a broth microdilution method with morpholinepropanesulfonic acid (...) pigs with cutaneous candidiasis and achieved mycological eradication in 8 of the 10 infected animals, whereas none of the imidazoles tested (1% solutions) was effective in even reducing the levels of the infecting fungi. KP-103 was as active as clotrimazole and neticonazole but was less active than lanoconazole and butenafine against Trichophyton rubrum (MIC at which 80% of isolates are inhibited [MIC(80)], 0.125 microg/ml) and Trichophyton mentagrophytes (MIC(80), 0.25 microg/ml). However, KP-103

Full Text available with Trip Pro

2001 Antimicrobial Agents and Chemotherapy

443. Congenital cutaneous candidiasis. (PubMed)

Congenital cutaneous candidiasis. 3420727 1988 10 25 2018 11 13 0041-6193 57 1 1988 Apr The Ulster medical journal Ulster Med J Congenital cutaneous candidiasis. 85-7 Tubman T R TR Reid M M MM eng Case Reports Journal Article Northern Ireland Ulster Med J 0417367 0041-6193 IM Candidiasis, Cutaneous congenital Humans Infant, Newborn Male 1988 4 1 1988 4 1 0 1 1988 4 1 0 0 ppublish 3420727 PMC2448466 Am J Dis Child. 1981 Mar;135(3):273-5 7211787 J Am Acad Dermatol. 1982 May;6(5):926-8 7096651

Full Text available with Trip Pro

1988 The Ulster medical journal

444. Fluconazole versus ketoconazole in the treatment of dermatophytoses and cutaneous candidiasis. (PubMed)

Fluconazole versus ketoconazole in the treatment of dermatophytoses and cutaneous candidiasis. 8002145 1995 01 26 2013 11 21 0011-9059 33 10 1994 Oct International journal of dermatology Int. J. Dermatol. Fluconazole versus ketoconazole in the treatment of dermatophytoses and cutaneous candidiasis. 726-9 Stengel F F Dermatology Division, CEMIC--University of Buenos Aires Medical School, Argentina. Robles-Soto M M Galimberti R R Suchil P P eng Clinical Trial Comparative Study Journal Article (...) Multicenter Study Randomized Controlled Trial England Int J Dermatol 0243704 0011-9059 0 Placebos 8VZV102JFY Fluconazole R9400W927I Ketoconazole IM Int J Dermatol. 1994 Oct;33(10):701 8002137 Int J Dermatol 1995 Mar;34(3):215 Adult Candida isolation & purification Candidiasis, Cutaneous drug therapy microbiology Double-Blind Method Female Fluconazole administration & dosage adverse effects therapeutic use Follow-Up Studies Humans Ketoconazole administration & dosage adverse effects therapeutic use Male

1995 International Journal of Dermatology Controlled trial quality: uncertain

445. A new treatment for cutaneous candidiasis: sulconazole nitrate cream 1%. (PubMed)

A new treatment for cutaneous candidiasis: sulconazole nitrate cream 1%. Sulconazole nitrate cream 1%, a new topical imidazole compound with a broad antifungal activity, was compared to its vehicle and to miconazole nitrate cream 2% in two double-blind parallel studies involving 96 patients with cutaneous candidiasis. Once daily application of sulconazole was as effective as twice daily application of miconazole and produced KOH and culture cures in 100% and 88% of patients, respectively

1983 International journal of dermatology Controlled trial quality: uncertain

446. Naftifine cream in the treatment of cutaneous candidiasis. (PubMed)

Naftifine cream in the treatment of cutaneous candidiasis. Naftifine, a member of a new class of synthetic antifungal drugs, the allylamines, was evaluated for the treatment of cutaneous candidiasis. In a double-blind, parallel-group clinical trial, sixty patients with cutaneous candidiasis were randomly assigned to receive either naftifine cream 1 percent or its vehicle twice a day for three weeks. Two weeks after the end of therapy, 77 percent of the naftifine-treated patients were

1988 Cutis; cutaneous medicine for the practitioner Controlled trial quality: uncertain

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>